Evidence map›Paper›PMID 41756605›Full record

ArticleDigital health

Predicting cardiovascular risk across cardiovascular-kidney-metabolic syndrome stages in middle-aged and older Chinese adults: An interpretable machine learning analysis.

Zhan Chen, Ruimin Lin, Yue Zhang

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhan ChenDepartment of Vascular Surgery, Beijing Haidian Hospital, Beijing, China.
Ruimin LinDepartment of Vascular Surgery, Beijing Haidian Hospital, Beijing, China.
Yue ZhangDepartment of Scientific Research, Beijing Haidian Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8017-6596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop and internally validate interpretable machine learning (ML) models for predicting incident cardiovascular disease (CVD) among middle-aged and older Chinese adults across cardiovascular-kidney-metabolic (CKM) stages 0-3, excluding CKM stage 4 (established CVD) by design, and to characterize stage-specific risk patterns using SHapley Additive exPlanations (SHAP). Methods: Using data from 6049 adults aged ≥45 years without baseline CVD in the China Health and Retirement Longitudinal Study, we developed interpretable ML models to predict incident, self-reported CVD during follow-up across CKM stages 0-3. Feature selection combining the Boruta algorithm with recursive feature elimination identified 11 key predictors. Five ML algorithms-logistic regression, random forest (RF), Extreme Gradient Boosting, Light Gradient Boosting Machine, and multilayer perceptron-were trained and evaluated using a stratified 70/30 train-test split. SHAP analysis enhanced model interpretability and characterized stage-specific risk profiles. Results: During a median 6-year follow-up, 1373 participants (22.7%) developed CVD, with incidence increasing progressively from 11.9% in Stage 0 to 24.4% in Stage 3 ( Conclusions: This interpretable ML framework provides a stage-specific CVD risk stratification approach across the CKM spectrum and may inform future risk assessment research in middle-aged and older Chinese adults. However, external validation and clinical utility evaluation are required before clinical translation.

Indexed as

cardiovascular diseaseCardiovascular–kidney–metabolic syndromemachine learningrisk predictionSHAP analysis

Identifiers

PMID41756605
PMCPMC12932883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.